Please note that assistive links (commonly known as "skip to links") are used throughout this site. These links are not well-supported by some mobile devices. If you are encountering difficulty using these links, please navigate around these links, or access the site on a desktop browser.
Skip to the primary content of this page Skip to the footer of this page

Q3 2024 Orthopedics Update

Skip to the end of the Expertise Menu

Q3 2024 Orthopedics Update

Orthopedic M&A activity remained stagnant in Q3 2024, with three reported strategic acquisitions, closely mirroring the deal flow of Q2 2023.

Despite a broader downturn in M&A activity, an ongoing payor-incentivized shift towards outpatient procedures is driving acquisition interest from a traditionally less-involved buyer group: ambulatory surgery center (ASC) management companies. Operators such as Surgery Partners are exploring partnership opportunities with orthopedic practices to capitalize on this trend, as evidenced by its recent roll-up of fourteen practices in Wisconsin.

Looking ahead, Provident anticipates accelerated deal volume through the remainder of 2024 and into 2025, as sponsors approach the tail end of PortCo investment holding periods and several sizable orthopedic opportunities near the closing of their sale processes.

To print and download the full Orthopedics Update report, please click below…

[holo_button icon=”/wp-content/uploads/2024/04/Q3-2024-Orthopedics-Newsletter_vP.pdf”” color=”#003561″ target=”blank”]PRINT/DOWNLOAD[/holo_button]